Tuesday, 27 June, 2017 - 08:30 to Wednesday, 28 June, 2017 - 15:00
Radisson Blu Aqua Hotel,
Chicago, IL, USA
This conference continues to serve as a global meeting place for those engaged in efforts to further drug development through new means of collaborations, including patient advocacy efforts and industry/academic/government cooperation.
A central focus at this year's event will be the use of repurposing to find and develop new therapies for rare diseases. Many rare diseases and disorders are serious conditions with no approved treatments. There is thus significant unmet needs for patients. The pharmaceutical industry has become engaged in a greater effort to develop drugs for these "orphan" indications. The FDA has supported this effort via various special protocols as well. There is a growing amount of evidence which suggests repurposing or repositioning research can greatly aid in the development of drugs for rare diseases. By using a more systematic approach, existing compounds are being tested for both common and neglected diseases faster and with more success.